FACTSHEET - 16.01.2017 Solactive Diabetes Total Return Index BESCHREIBUNG Der Solactive Diabetes Performance-Index bildet die Kursentwicklung internationaler Unternehmen ab, die als Hauptgeschäftszweck die Heilung und Linderung von Diabetes-Patienten haben. Die Gesellschaften müssen einen bedeutenden Teil ihrer Umsätze im Bereich Diabetes erzielen oder Produkte in der Pipeline haben, die in der Zukunft für einen signifikanten Umsatzbeitrag in diesem Bereich sorgen werden. HISTORISCHE WERTENTWICKLUNG* 300 250 200 150 100 50 Jan-2008 Jan-2010 Jan-2012 Jan-2014 Jan-2016 STAMMDATEN ISIN/WKN Bloomberg / Reuters Index Berechner Index Typ Index Währung Index Komponenten Dividenden DE000A0JZJM2 / A0JZJM SBOXDP Index / .SBOXDIAB Solactive AG Industry / Sector EUR 10 Reinvested (Total Return Index) Basiswert / Basisdatum 100 Points / 08.12.2006 Aktueller Stand 259.82 52W Hoch 287.35 52W Tief Berechnung Historie 213.85 09:00am to 10:30pm (CET), every 60 seconds Available daily back to 08.12.2006 FACTSHEET - 16.01.2017 Solactive Diabetes Total Return Index STATISTIKEN EUR Performance Performance (p.a.) 30T 90T 180T 360T lfd. J Seit Auflage 6.7% 1.5% -7.6% -2.8% 7.9% 160.0% 120.3% 6.1% -14.8% -2.9% 461.8% 9.9% Volatilität (p.a.) 23.1% 29.6% 23.3% 24.5% 30.0% 24.7% Hoch 259.82 260.36 287.35 287.35 259.82 304.80 Tief 240.90 214.16 214.16 213.85 243.24 43.41 5.22 0.22 -0.63 -0.11 15.38 0.41 -2.4% -17.7% -25.5% -25.5% -1.4% -59.2% Sharpe Ratio Max. Drawdown VaR 95 \ 99 CVaR 95 \ 99 WÄHRUNGS EXPOSURE -37.9%\-82.0% -37.0%\-71.8% -64.0%\-113.4% -57.0%\-90.2% LÄNDER EXPOSURE US 59.7% USD 59.7% DK 26.3% DKK 26.3% CH 6.0% EUR 7.9% DE 4.4% CHF 6.0% Others 3.5% TOP KOMPONENTEN Ticker Währung Land Firma Gewicht LLY UN Equity USD US ELI LILLY & CO 25.95% NOVOB DC Equity DKK DK NOVO NORDISK A/S 22.68% DXCM UW Equity USD US DEXCOM INC 19.11% PODD UW Equity USD US INSULET CORP 6.67% YPSN SE Equity CHF CH YPSOMED HOLDING AG 5.98% EVT GY Equity EUR DE EVOTEC 4.42% LXRX UW Equity USD US LEXICON PHARMACEUTICALS INC 4.15% MNKD UQ Equity USD US MANNKIND CORP 3.86% FACTSHEET - 16.01.2017 Solactive Diabetes Total Return Index Realtime Preise, einen Index Guide sowie weitere Informationen finden Sie auf www.solactive.com * Past performance is no guarantee of future results and may be lower or higher than current performance. Index returns are no guarantee for any returns of financial products linked to the index. Any performance information regarding financial products linked to the index can reflect temporary waivers of expenses and/or fees and does not include insurance/annuity fees and expenses. This info service is offered exclusively by Solactive AG, Guiollettstr. 54, D-60325 Frankfurt am Main, E-Mail [email protected] | Disclaimer: The financial instrument is not sponsored, promoted, sold or supported in any other manner by Solactive AG nor does Solactive AG offer any express or implicit guarantee or assurance either with regard to the results of using the Index and/or Index trade mark or the Index Price at any time or in any other respect. The Index is calculated and published by Solactive AG. Solactive AG uses its best efforts to ensure that the Index is calculated correctly. Irrespective of its obligations towards the Issuer, Solactive AG has no obligation to point out errors in the Index to third parties including but not limited to investors and/or financial intermediaries of the financial instrument. Neither publication of the Index by Solactive AG nor the licensing of the Index or Index trade mark for the purpose of use in connection with the financial instrument constitutes a recommendation by Solactive AG to invest capital in said financial instrument nor does it in any way represent an assurance or opinion of Solactive AG with regard to any investment in this financial instrument. This document is for the information and use of professional advisers only. Remember, the information in this document does not constitute tax, legal or investment advice and is not intended as a recommendation for buying or selling securities. The information and opinions contained in this document have been obtained from public sources believed to be reliable, but no representation or warranty, express or implied, is made that such information is accurate or complete and it should not be relied upon as such. Solactive AG and all other companies mentioned in this document will not be responsible for the consequences of reliance upon any opinion or statement contained herein or for any omission. | Solactive AG, 2013. All rights reserved.